Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Biochemistry

• Publication date

  1998-11-17

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI980871+PMID 9819232
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional expression of human P-glycoprotein from plasmids using vaccinia virus-bacteriophage T7 RNA polymerase system.

  1998cited by this paper
• Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein.

  1997cited by this paper
• Multidrug-resistant Human Sarcoma Cells with a Mutant P-Glycoprotein, Altered Phenotype, and Resistance to Cyclosporins*

  1997cited by this paper
• Mutagenesis of transmembrane domain 11 of P-glycoprotein by alanine scanning.

  1996cited by this paper
• Characterization of Phosphorylation-defective Mutants of Human P-glycoprotein Expressed in Mammalian Cells (*)

  1996cited by this paper
• Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators.

  1995cited by this paper
• Genetic analysis of the multidrug transporter.

  1995cited by this paper
• P-glycoprotein Is Stably Inhibited by Vanadate-induced Trapping of Nucleotide at a Single Catalytic Site (*)

  1995cited by this paper
• Functional consequences of glycine mutations in the predicted cytoplasmic loops of P-glycoprotein.

  1994cited by this paper
• Localization of the forskolin labeling sites to both halves of P-glycoprotein: similarity of the sites labeled by forskolin and prazosin.

  1994cited by this paper
• Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein.

  1994cited by this paper
• Functional consequences of phenylalanine mutations in the predicted transmembrane domain of P-glycoprotein.

  1993cited by this paper
• Biochemistry of multidrug resistance mediated by the multidrug transporter.

  1993cited by this paper
• Functional consequences of proline mutations in the predicted transmembrane domain of P-glycoprotein.

  1993cited by this paper
• Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase.

  1992cited by this paper
• Functional analysis of chimeric proteins constructed by exchanging homologous domains of two P-glycoproteins conferring distinct drug resistance profiles.

  1992cited by this paper
• Pseudomonas exotoxin fusion proteins are potent immunogens for raising antibodies against P-glycoprotein.

  1991cited by this paper
• Domain mapping of the photoaffinity drug-binding sites in P-glycoprotein encoded by mouse mdr1b.

  1991cited by this paper
• Vaccinia virus: a tool for research and vaccine development

  1991cited by this paper
• Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system.

  1989cited by this paper
• Two different regions of P-glycoprotein [corrected] are photoaffinity-labeled by azidopine.

  1989cited by this paper
• Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

  1986cited by this paper

• In vitro identification of decreased function genetic variants of ABCB1.

  2025cites this paper
• Theoretical insights on helix repacking as the origin of P-glycoprotein promiscuity

  2020cites this paper
• Flavonoids as P-gp inhibitors: a systematic review of SARs.

  2019cites this paper
• MDR1 in immunity: friend or foe?

  2018cites this paper
• Bioenergetic coupling in P-glycoprotein: determining the relative position, topography and role of transmembrane helices six and twelve

  2018cites this paper
• Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein.

  2016cites this paper
• Unravelling the complex drug–drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein

  2016cites this paper
• Genetic Polymorphisms of P-glycoprotein: Echoes of Silence

  2016cites this paper
• Just How and Where Does P-glycoprotein Bind All Those Drugs?

  2016cites this paper
• P‐Glycoprotein Mediated Drug Interactions in Animals and Humans with Cancer

  2015cites this paper
• Systematic Review of Prognostic Factors for Mortality in Dogs with Immune‐mediated Hemolytic Anemia

  2015cites this paper
• New insights into the mechanisms of multidrug resistance in cancers.

  2015cites this paper
• Regulations of P-Glycoprotein/ABCB1/MDR1 in Human Cancer Cells

  2014cites this paper
• Human and rat ABC transporter efflux of bisphenol a and bisphenol a glucuronide: interspecies comparison and implications for pharmacokinetic assessment.

  2012cites this paper
• 8.8 Molecular Aspects of the Translocation Process by ABC Proteins

  2012cites this paper
• New insight into p-glycoprotein as a drug target.

  2012cites this paper
• Multidrug efflux pumps: drug binding – gates or cavity?

  2010cites this paper
• Molecular mechanisms of adaptation to folate deficiency.

  2008cites this paper
• Identification of Putative Binding Sites of P‐glycoprotein Based on its Homology Model

  2008cites this paper
• Clinical pharmacogenetics and potential application in personalized medicine.

  2008cites this paper
• Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition

  2008cites this paper
• P-Glycoprotein in Proteoliposomes with Low Residual Detergent: The Effects of Cholesterol

  2007cites this paper
• Identification of the Substrate Binding Region of Vesicular Monoamine Transporter-2 (VMAT-2) Using Iodoaminoflisopolol as a Novel Photoprobe

  2007cites this paper
• Molecular basis of antifolate resistance

  2007cites this paper
• How can we best use structural information on P-glycoprotein to design inhibitors?

  2007cites this paper
• The nature of amino acid 482 of human ABCG2 affects substrate transport and ATP hydrolysis but not substrate binding

  2006cites this paper
• The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.

  2006cites this paper
• New light on multidrug binding by an ATP-binding-cassette transporter.

  2006cites this paper
• Role of transmembrane domain/transmembrane domain interfaces of P-glycoprotein (ABCB1) in solute transport. Convergent information from photoaffinity labeling, site directed mutagenesis and in silico importance prediction.

  2006cites this paper
• Single nucleotide polymorphisms in human P-glycoprotein: its impact on drug delivery and disposition

  2006cites this paper
• Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.

  2006cites this paper
• Role of ABCG2/BCRP in biology and medicine.

  2006cites this paper
• Insight in eukaryotic ABC transporter function by mutation analysis

  2006cites this paper
• P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy.

  2005cites this paper
• An Interethnic Comparison of Polymorphisms of the Genes Encoding Drug-Metabolizing Enzymes and Drug Transporters: Experience in Singapore

  2005cites this paper
• P-Glycoprotein Substrate Binding Domains Are Located at the Transmembrane Domain/Transmembrane Domain Interfaces: A Combined Photoaffinity Labeling-Protein Homology Modeling Approach

  2005cites this paper
• The coupling mechanism of P‐glycoprotein involves residue L339 in the sixth membrane spanning segment

  2005cites this paper
• The ABC Transporter Abcg2/Bcrp: Role in Hypoxia Mediated Survival

  2005cites this paper
• A critical role of a carboxylate in proton conduction by the ATP‐binding cassette multidrug transporter LmrA

  2005cites this paper
• Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition.

  2005cites this paper
• Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators.

  2004cites this paper
• ABCG2 – a transporter for all seasons

  2004cites this paper
• The Topography of Transmembrane Segment Six Is Altered during the Catalytic Cycle of P-glycoprotein*

  2004cites this paper
• Overexpression, purification, and functional characterization of ATP-binding cassette transporters in the yeast, Pichia pastoris.

  2003cites this paper
• Functional Importance of Polar and Charged Amino Acid Residues in Transmembrane Helix 14 of Multidrug Resistance Protein 1 (MRP1/ABCC1)

  2003cites this paper
• Allosteric Modulation of Human P-glycoprotein

  2003cites this paper
• CHAPTER 27 – THE SULFONYLUREA RECEPTOR: AN ABCC TRANSPORTER THAT ACTS AS AN ION CHANNEL REGULATOR

  2003cites this paper
• CHAPTER 5 – SUBSTRATE-BINDING SITES IN ABC TRANSPORTERS

  2003cites this paper
• A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance.

  2002cites this paper
• Monoclonal antibodies as a tool for structure-function studies of the MDR1-P-glycoprotein.

  2002cites this paper
• Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system.

  2002cites this paper
• Multidrug resistance and cancer: the role of the human ABC transporter ABCG2.

  2002cites this paper
• Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations.

  2002cites this paper
• Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein low-level expressing erythrocytes.

  2001cites this paper
• Transmembrane domain (TM) 9 represents a novel site in P-glycoprotein that affects drug resistance and cooperates with TM6 to mediate [125I]iodoarylazidoprazosin labeling.

  2001cites this paper
• The Mechanism of Action of Multidrug-Resistance-Linked P-Glycoprotein

  2001cites this paper
• Further characterization of the sixth transmembrane domain of Pgp1 by site-directed mutagenesis

  2001cites this paper
• Identification of a Nonconserved Amino Acid Residue in Multidrug Resistance Protein 1 Important for Determining Substrate Specificity

  2001cites this paper
• Molecular genetic analysis and biochemical characterization of mammalian P-glycoproteins involved in multidrug resistance.

  2001cites this paper
• Erythrocyte membrane ATP binding cassette (ABC) proteins: MRP1 and CFTR as well as CD39 (ecto-apyrase) involved in RBC ATP transport and elevated blood plasma ATP of cystic fibrosis.

  2001cites this paper
• Structure-activity relationships of multidrug resistance reversers.

  2001cites this paper
• Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene.

  2001cites this paper
• Analysis of MDR1 P-glycoprotein conformational changes in permeabilized cells using differential immunoreactivity.

  2001cites this paper
• Apoptosis induced by doxorubicin and cinchonine in P388 multidrug‐resistant cells

  2001cites this paper
• The human ATP-binding cassette (ABC) transporter superfamily.

  2001cites this paper
• Cross-linking of Human Multidrug Resistance P-glycoprotein by the Substrate, Tris-(2-maleimidoethyl)amine, Is Altered by ATP Hydrolysis

  2001cites this paper
• The use of a novel taxane-based P-glycoprotein inhibitor to identify mutations that alter the interaction of the protein with paclitaxel.

  2001cites this paper
• Mutation of a Single Conserved Tryptophan in Multidrug Resistance Protein 1 (MRP1/ABCC1) Results in Loss of Drug Resistance and Selective Loss of Organic Anion Transport*

  2001cites this paper
• Chemoprotection of Hematopoietic Cells by a Mutant P-Glycoprotein Resistant to a Potent Chemosensitizer of Multidrug-Resistant Cancers

  2000cites this paper
• Phospholipids as multidrug resistance modulators of the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats.

  2000cites this paper
• Functional analysis of a tryptophan-less P-glycoprotein: a tool for tryptophan insertion and fluorescence spectroscopy.

  2000cites this paper
• Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.

  2000cites this paper
• The Packing of the Transmembrane Segments of Human Multidrug Resistance P-glycoprotein Is Revealed by Disulfide Cross-linking Analysis*

  2000cites this paper
• Activation of the human P-glycoprotein ATPase by trypsin.

  2000cites this paper
• Polymorphismes du gene mdr-1 humain et leur utilisation dans des applications diagnostiques et therapeutiques

  2000cites this paper
• Determining the structure and mechanism of the human multidrug resistance P-glycoprotein using cysteine-scanning mutagenesis and thiol-modification techniques.

  1999cites this paper
• Photoaffinity analogs for multidrug resistance-related transporters and their use in identifying chemosensitizers.

  1999cites this paper
• A single amino acid residue contributes to distinct mechanisms of inhibition of the human multidrug transporter by stereoisomers of the dopamine receptor antagonist flupentixol.

  1999cites this paper
• Large Scale Purification of Detergent-soluble P-glycoprotein fromPichia pastoris Cells and Characterization of Nucleotide Binding Properties of Wild-type, Walker A, and Walker B Mutant Proteins*

  1999cites this paper
• Identification of P-glycoprotein Mutations Causing a Loss of Steroid Recognition and Transport*

  1999cites this paper
• Domain exchangeability between the multidrug transporter (MDR1) and phosphatidylcholine flippase (MDR2).

  1999cites this paper
• Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

  1999cites this paper
• Studies of Human MDR1-MDR2 Chimeras Demonstrate the Functional Exchangeability of a Major Transmembrane Segment of the Multidrug Transporter and Phosphatidylcholine Flippase

  1999cites this paper
• Identification of Residues in the Drug-binding Domain of Human P-glycoprotein

  1999cites this paper